Pnc Financial Services Group, Inc. Century Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,027 shares of IPSC stock, worth $3,794. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,027Holding current value
$3,794% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
69Shares Held
26.9MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$2.92 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$1.73 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.56 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.35 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.28 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $31.8M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...